Skip to content

ICAAC: Achillion reveals potential for once weekly dosing of nucleoside analogue

South African study finds many patients die waiting for treatment after enrolment into antiretroviral rollout programme

ICAAC: No added benefit from adding AZT to nevirapine to prevent MTCT

UK Government to be sued over lack of PEP policy for sexual exposure to HIV

ICAAC: Nevirapine and rifampicin can be safely used together

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

New study looks at impact of AIDS on South Africa

Advocacy groups demand equal HIV treatment access for injecting drug users

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T